Bionano Genomics, Inc. Common Stock BNGO
$1.23
+2.49%
at last close
Financials (TTM)
- Revenue
- $30.18 million
- Net Income
- $-32,162,000
- Net Margin
- -106.58%
- Return on Equity
- -101.76%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 0.45
- Price / Sales
- 0.47
Over the trailing twelve months, Bionano Genomics, Inc. Common Stock generated revenue of $30.18 million and net income of $-32,162,000, a net margin of -106.58%.
At the last closing price of $1.23, BNGO trades at 0.47 times sales, with a market capitalization of $14.13 million.
Key Stats
- Last Close
- $1.23
- Market Cap
- $14.13 million
- 52-Week Range
- $1.00 – $5.50
- Average Volume
- 157K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.
